Pharmafile Logo

News and Press Releases

BIO-Europe® 2025 Gathers Global Life Sciences Leaders in Vienna

2 July 2025 -- Munich, Germany -- The 31st annual edition of BIO-Europe, the premier partnering conference for the global biopharmaceutical industry, will take place in Vienna, Austria, from November...

Category: Biotechnology, Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: July 2, 2025

BIO-Europe 2025
EBDcustomerservice@ebdgroup.com

PHARMASEAL and Viedoc Announce a Technical Integration Partnership

July 2, 2025 – Nottingham, UK – PHARMASEAL, provider of the Engility Trial Management Platform consisting of a Clinical Trial Management System (CTMS) CTMS and Electronic Trial Master File (eTMF),...

Category:
Posted: July 2, 2025

PHARMASEAL
info@pharmaseal.co
Ingenuity Centre, Nottingham University Innovation Park Triumph Road, Nottingham, NG7 2TU, United Kingdom

Iksuda Therapeutics receives FDA IND clearance for IKS014

FDA decision will enable Iksuda to expand its ongoing clinical trial in the US, Australia and Singapore Preliminary data from an ongoing dose-escalation study of IKS014 has shown meaningful clinical activity across...

Category: Biotechnology, Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: July 1, 2025

Iksuda
The Biosphere, Draymans Way, Newcastle Helix Newcastle upon Tyne NE4 5BX

Healthcare Finance and Smart Materials Experts Delivering Opening and Closing Plenaries at PharmSci 360

26 June 2025 -- Virginia, US -- AAPS is excited to announce the opening and closing plenary speakers for the 2025 PharmSci 360, taking place November 9-12, in San Antonio,...

Category: Biotechnology, Drug Delivery, Logistics, Other, Pharmaceutical
Posted: June 26, 2025

American Association of Pharmaceutical Scientists (AAPS)
aaps@aaps.org
2107 Wilson Blvd #200 Arlington, VA 22201

Oxeltis and academic partners receive grant funding worth nearly €800,000 to develop antiviral for Bunyaviricetes 

France’s National Research Agency (ANR) and Defense Innovation Agency (AID) will finance BUNYANTIVIR project to introduce novel therapeutic approach for Bunyaviricetes class of human pathogenic viruses found in tropical and...

Category:
Posted: June 25, 2025

Oxeltis
Cap Gamma, 1682 rue de la Valsière, BP 7247 34086 Montpellier Cedex 4 – France

Novo Nordisk A/S: Ozempic receives EU recommendation in peripheral arterial disease, cementing the broad benefits of semaglutide for people with type 2 diabetes and comorbidities

Pending a decision from the European Commission, Ozempic (once-weekly semaglutide) will have the broadest approved label in the glucagon-like peptide-1 receptor agonist (GLP-1 RA) class, demonstrating improvements in blood sugar,...

Category: Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: June 23, 2025

Novo Nordisk
abmo@novonordisk.com
Novo Nordisk A/S Novo Allé, 2880 Bagsvaerd Denmark

argenx Announces European Commission Approval of VYVGART Subcutaneous Injection for Chronic Inflammatory Demyelinating Polyneuropathy

VYVGART® SC, first-and-only IgG Fc-antibody fragment which specifically targets the neonatal Fc receptor (FcRn), now approved for use in Europe for CIDP Approval based on ADHERE clinical trial, the largest...

Category: Biotechnology, Clinical Trials, Other, Pharmaceutical
Posted: June 20, 2025

argenx
ukmediainfo@argenx.com
Spaces Gerrards Cross Chalfont Park, Building 1 Gerrards Cross, SL9 0BG

Neopac Wins Two Prestigious Tube of the Year Awards from the US Tube Council

Oberdiessbach, Switzerland – Neopac, a global provider of high-quality packaging and dosing applications for pharma, beauty and oral care, has received two prestigious Tube of the Year Awards from the...

Category:
Posted: June 20, 2025

Neopac
info@neopac.com
3672 Oberdiessbach

New Reverse Osmosis (RO) pure water dialysis system unveiled by NIPRO at ERA 2025

19 June 2025 -- Osaka, Japan -- NIPRO announces the launch of LiniXia, a strategic addition to its dialysis portfolio in next-generation reverse-osmosis (RO) water treatment. The new LiniXia RO...

Category: Biotechnology, Drug Delivery, Other, Pharmaceutical
Posted: June 19, 2025

Nipro Medical Corporation
info@nipromed.com

Sanner starts manufacturing in Greensboro, USA

18 June 2025 -- North Carolina, US -- Sanner has officially launched manufacturing operations in Greensboro, North Carolina. The new facility is dedicated to producing critical injection-molded components for medical...

Category: Logistics, Manufacturing and Packing, Other, Pharmaceutical, Pharmaceutical Contractors
Posted: June 18, 2025

Sanner
info@sanner-group.com
Schillerstrasse 76 64625 Bensheim

Celltrion opens new UK headquarters in Uxbridge, UK

New office located in the heart of Uxbridge underscores Celltrion’s long-term business commitment in the UK 17 June 2025 -- London, UK -- Celltrion UK has officially opened its new...

Category: Clinical Trials, Drug Discovery, Manufacturing and Packing, Other, Pharmaceutical
Posted: June 17, 2025

Celltrion
23, Academy-ro, Yeonsu-gu, Incheon, Republic of Korea

SolasCure receives FDA Fast Track Designation for Aurase Wound Gel to treat calciphylaxis ulcers

Recognises the potential of Aurase Wound Gel to improve outcomes for individuals with calciphylaxis ulcers, a rare and life-threatening condition Represents a new indication for Aurase Wound Gel, currently in...

Category: Biotechnology, Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: June 16, 2025

SolasCure
wellington house East Rd, Petersfield, Cambridge CB1 1BH

Kite’s CAR T-Cell Therapy Data Show Real-World Patient Benefit and Durable Response Across Difficult-to-Treat Blood Cancers

Largest Real-World (RW) Analyses of Yescarta® (Axicabtagene Ciloleucel) Show 74% Overall Survival (OS) at 12 Months in Second-Line Relapsed/Refractory Large B-cell Lymphoma (LBCL), Consistent with OS Reported in Pivotal ZUMA-7 Study,...

Category: Biotechnology, Clinical Trials, Drug Delivery, Drug Discovery, Other, Pharmaceutical
Posted: June 12, 2025

Kite Pharma
2400 Broadway Santa Monica, CA 90404

Lightning-Fast Gut Microbiome Analysis Opens New Doors for Health and Industry

12 June 2025 -- Leuven, Belgium -- A revolution in gut microbiome research is on the horizon. Biotech company Perseus Biomics and hardware developer Comate are launching MetaMAP, a groundbreaking...

Category: Biotechnology, Drug Discovery, Other, Pharmaceutical
Posted: June 12, 2025

Perseus Biomics
info@perseusbiomics.com
Gaston Geenslaan 3 3001 Leuven, Belgium

Northern Gritstone invests in Manchester spinout Apini

Northern Gritstone has committed £1.8 million to Apini, a spinout from the University of Manchester Apini is a novel small molecule therapeutic programme for the treatment of multiple chronic inflammatory...

Category: Biotechnology, Other, Pharmaceutical
Posted: June 11, 2025

Northern Gritstone
enquiries@northern-gritstone.com
No.1 Circle Square 3 Symphony Park Manchester M1 7FS